19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Huamin Li is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Hereditary Angioedemas Medicine & Life Sciences
Complement C1 Inhibitor Protein Medicine & Life Sciences
Angioedema Medicine & Life Sciences
Placebos Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Safety Medicine & Life Sciences
Plasma Kallikrein Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study

SAHARA study group, May 1 2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 5, p. 1610-1618.e4

Research output: Contribution to journalArticle

Open Access
Hereditary Angioedemas
Placebos
Safety
Therapeutics
Hereditary Angioedema Types I and II

Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks

Bernstein, J. A., Li, H., Craig, T. J., Manning, M. E., Lawo, J. P., Machnig, T., Krishnarajah, G. & Fridman, M., Mar 7 2019, In : Allergy, Asthma and Clinical Immunology. 15, 1, 13.

Research output: Contribution to journalArticle

Open Access
Hereditary Angioedemas
Placebos
Odds Ratio
Therapeutics
Cross-Over Studies

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: Additional outcomes and subgroup analysis of a placebo-controlled randomized study

Li, H., Zuraw, B., Longhurst, H. J., Cicardi, M., Bork, K., Baker, J., Lumry, W., Bernstein, J., Manning, M., Levy, D., Riedl, M. A., Feuersenger, H., Prusty, S., Pragst, I., Machnig, T. & Craig, T., Aug 28 2019, In : Allergy, Asthma and Clinical Immunology. 15, 1, 49.

Research output: Contribution to journalArticle

Open Access
Hereditary Angioedemas
Complement C1 Inhibitor Protein
Placebos
Therapeutics
Hereditary Angioedema Types I and II

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study

Riedl, M. A., Aygören-Pürsün, E., Baker, J., Farkas, H., Anderson, J., Bernstein, J. A., Bouillet, L., Busse, P., Manning, M., Magerl, M., Gompels, M., Huissoon, A. P., Longhurst, H., Lumry, W., Ritchie, B., Shapiro, R., Soteres, D., Banerji, A., Cancian, M., Johnston, D. T. & 17 others, Craig, T. J., Launay, D., Li, H., Liebhaber, M., Nickel, T., Offenberger, J., Rae, W., Schrijvers, R., Triggiani, M., Wedner, H. J., Dobo, S., Cornpropst, M., Clemons, D., Fang, L., Collis, P., Sheridan, W. P. & Maurer, M., Sep 1 2018, In : Allergy: European Journal of Allergy and Clinical Immunology. 73, 9, p. 1871-1880 10 p.

Research output: Contribution to journalArticle

Hereditary Angioedemas
Kallikreins
Angioedema
Placebos
Plasma Kallikrein

Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema

Lumry, W. R., Craig, T., Zuraw, B., Longhurst, H., Baker, J., Li, H., Bernstein, J. A., Anderson, J., Riedl, M. A., Manning, M. E., Keith, P. K., Levy, D. S., Caballero, T., Banerji, A., Gower, R. G., Farkas, H., Lawo, J. P., Pragst, I., Machnig, T. & Watson, D. J., Jan 1 2018, (Accepted/In press) In : Journal of Allergy and Clinical Immunology: In Practice.

Research output: Contribution to journalArticle

Hereditary Angioedemas
Quality of Life
Placebos
Anxiety
Efficiency